Kala Bio (KALA) Other Operating Expenses (2016 - 2025)
Kala Bio (KALA) posted Other Operating Expenses of -$3.4 million for Q3 2025, down 2336.6% sequentially from $153000.0 in Q2 2025, and down 914.76% YoY from $420000.0 in Q3 2024.
Kala Bio (KALA) Other Operating Expenses (2016 - 2025) Analysis & Trends
Kala Bio has reported Other Operating Expenses for 10 years, with the latest figure at -$3.4 million in Q3 2025.
- Quarterly Other Operating Expenses fell 914.76% year-over-year to -$3.4 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (down 893.45% YoY) and the FY2025 annual result came in at -$3.2 million, down 691.62% from the prior year.
- Other Operating Expenses declined to -$3.4 million in Q3 2025 per KALA's latest filing, from $153000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $47.0 million in Q3 2022 and troughed at -$7.5 million in Q2 2021.
- A 5-year average of $1.7 million and a median of -$29000.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Other Operating Expenses surged 2385.75% in 2022, then tumbled 914.76% in 2025.
- Over 5 years, Other Operating Expenses stood at -$753000.0 in 2021, then soared by 6341.04% to $47.0 million in 2022, then sank by 99.41% to $278000.0 in 2023, then jumped by 51.08% to $420000.0 in 2024, then sank by 914.76% to -$3.4 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$3.4 million, $153000.0, and $21000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kala Bio | 9.89 Mn | 9.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | 153,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Sep 30, 2024 | 420,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | 278,000.00 |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | 359,000.00 |
| Mar 31, 2023 | 1.62 Mn |
| Sep 30, 2022 | 47.00 Mn |
| Jun 30, 2022 | -2.14 Mn |
| Mar 31, 2022 | -2.03 Mn |
| Dec 31, 2021 | -753,000.00 |
| Sep 30, 2021 | -2.06 Mn |
| Jun 30, 2021 | -7.45 Mn |
| Mar 31, 2021 | -2.10 Mn |
| Dec 31, 2020 | -2.13 Mn |
| Sep 30, 2020 | -2.11 Mn |
| Jun 30, 2020 | -2.03 Mn |